×
For best experience we recommend to activate Javascript in your browser.
AKR1C4 antibody (N-Term)
The Rabbit Polyclonal anti-AKR1C4 antibody has been validated for WB and ELISA. It is suitable to detect AKR1C4 in samples from Human.
Quick Overview for AKR1C4 antibody (N-Term) (ABIN2198345)
Target
See all AKR1C4 Antibodies
AKR1C4
(Aldo-keto Reductase Family 1 Member C4 (AKR1C4))
Reactivity
All reactivities for AKR1C4 antibodies
Human
Host
All hosts for AKR1C4 antibodies
Rabbit
Clonality
All clonalities for AKR1C4 antibodies
Polyclonal
Conjugate
All conjugates for AKR1C4 antibodies
This AKR1C4 antibody is un-conjugated
Application
All applications for AKR1C4 antibodies
Western Blotting (WB), ELISA
Product Details anti-AKR1C4 Antibody
(hide)
Binding Specificity
All epitopes for AKR1C4 antibodies
AA 10-39, N-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
AKR1C4, NT (AKR1C4, CHDR, Aldo-keto reductase family 1 member C4, 3-alpha-HSD1, 3-alpha-hydroxysteroid dehydrogenase type I, Chlordecone reductase, Dihydrodiol dehydrogenase 4, HAKRA)
Purification
Purified by Protein A affinity chromatography.
Immunogen
AKR1C4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 10-39 amino acids from the N-terminal region of human AKR1C4.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for AKR1C4
(hide)
Target
AKR1C4
(Aldo-keto Reductase Family 1 Member C4 (AKR1C4))
Alternative Name
AKR1C4
NCBI Accession
NP_001809
UniProt
P17516
Pathways
Steroid Hormone Biosynthesis
Recently viewed
(hide)
Chat with us , powered by LiveChat